Lu Chen

197 Ruijin Second Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

P4HA3-mediated hydroxylation of SLC7A11 drives tyrosine kinase inhibitor resistance by suppressing ferroptosis in clear cell renal cell carcinoma.

P4HA3-mediated hydroxylation of SLC7A11 drives tyrosine kinase inhibitor resistance by suppressing ferroptosis in clear cell renal cell carcinoma.

Journal: Redox biology

Published: May 25, 2026

Analysis of paired primary-metastatic renal cancer lesions reveals RCN3-MMP10 axis facilitates lung metastasis.

Analysis of paired primary-metastatic renal cancer lesions reveals RCN3-MMP10 axis facilitates lung metastasis.

Journal: Cellular signalling

Published: December 12, 2025

Application of three-anatomical-plane dissection technique in the partial nephrectomy of renal cell carcinoma abutting the hilum gulf.

Application of three-anatomical-plane dissection technique in the partial nephrectomy of renal cell carcinoma abutting the hilum gulf.

Journal: World journal of surgical oncology

Published: August 30, 2025

The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance.

The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance.

Journal: Journal of translational medicine

Published: April 08, 2023

A novel spraying nanoprobe for renal cell carcinoma in humans.

A novel spraying nanoprobe for renal cell carcinoma in humans.

Journal: Life medicine

Published: July 11, 2022

Exploration of the cancer genome atlas database reveals genes of interest related with cancer cell stemness indices in clear cell renal cell carcinoma.

Exploration of the cancer genome atlas database reveals genes of interest related with cancer cell stemness indices in clear cell renal cell carcinoma.

Journal: Heliyon

Published: December 20, 2021

Aberrant activation of m6A demethylase FTO renders HIF2αlow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors.

Aberrant activation of m6A demethylase FTO renders HIF2αlow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors.

Journal: Science translational medicine

Published: September 29, 2021

Tubulocystic renal cell carcinoma: Two-case report and literature review.

Tubulocystic renal cell carcinoma: Two-case report and literature review.

Journal: International journal of immunopathology and pharmacology

Published: March 17, 2021

Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.

Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.

Journal: Clinical and translational medicine

Published: December 03, 2020

EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.

EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.

Journal: EBioMedicine

Published: September 02, 2019

α-Viniferin activates autophagic apoptosis and cell death by reducing glucocorticoid receptor expression in castration-resistant prostate cancer cells.

α-Viniferin activates autophagic apoptosis and cell death by reducing glucocorticoid receptor expression in castration-resistant prostate cancer cells.

Journal: Medical oncology (Northwood, London, England)

Published: May 21, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026